Please assess the completion status of the following clinical trial:

Trial Title: Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatient Setting

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Chemotherapy because of malignancy~* Severe neutropenia (absolute neutrophil count ≤ 0.5x10E9/L)~* Fever (axillary temperature ≥ 38.5°C once or ≥ 38.0°C during ≥ 2 hours)~* Able to swallow oral medication~* Written informed consent from patients and/or parents~Exclusion Criteria:~* Status post myeloablative chemotherapy~* Diagnosis: acute myeloid leukemia, B-cell acute lymphoblastic leukemia, or B-cell Non-Hodgkin lymphoma~* Bone marrow involvement by malignancy ≥ 25%~* Any comorbidity requiring hospitalization: \[1\] mean arterial blood pressure \< 50 mmHg (up to 10 years) / \< 60 mmHg (older than 10 years); \[2\] oxygen saturation \< 94% at room air; \[3\] radiologically defined pneumonia; \[4\] focal bacterial infection; \[5\] blood cultures taken at presentation reported positive at reassessment; \[6\] need for inpatient treatment or observation due to any other reason, as judged by the physician in charge~* Ever shaking chills~* Ever axillary temperature ≥ 39.5°C~* Antibacterial treatment before presentation with fever and neutropenia (except for prevention against Pneumocystis jiroveci \[formerly P. carinii\] pneumonia)~* Modification or de novo institution of a prophylaxis against P. jiroveci pneumonia~* Modification or de novo institution of a therapy with G-CSF or GM-CSF.~* Allergy to ciprofloxacin and/or amoxicillin~* Serum creatinine level above the upper limit of normal range

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 18 Years
- Healthy Volunteers: f

Study Arms:
- Standard (Type: ACTIVE_COMPARATOR): Continued inpatient i.v. antibiotics
- Experimental (Type: EXPERIMENTAL): Switch to outpatient p.o. antibiotics

Based on this trial design, predict the completion outcome and termination type (if applicable).